Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents

Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim Order (IO) No. 2. 2021-05-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyguidance documentInterim OrderIO No.2coronavirusCOVID-19clinical trialsdrugmedical deviceclinical trial authorizationdrug approval Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documentsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/interim-order-2-clinical-trials-medical-devices-drugs/guidance-documents-notice.html Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documentsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/arrete-urgence-no-2-cliniques-instruments-medicaux-drogues/note-explanative/lignes-directrices-avis.html

The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim Order (IO) No. 2.

Data and Resources

Similar records